EKOÏ is becoming helmets and eyewear partner of DATEV Challenge Roth powered by hep

From next season: high-quality cycling glasses and helmets in an exclusive ROTH design

The French helmet and cycling glasses expert Ekoi is the new partner of the largest long-distance triathlon in the world. With the new partnership, Ekoi will work with TEAMCHALLENGE to develop exclusive products dedicated solely to DATEV Challenge Roth powered by hep.

Race director Felix Walchshöfer: “We are happy to be able to count on Ekoï, an excellent partner for helmets and sports glasses. As equipment supplier to ROTH champions Anne Haug and Patrick Lange, the brand impressively shows that it stands for absolute top quality and is therefore perfect for our race. Thanks to this partnership, all ROTH fans can rejoice because from next season, there will also be cycling glasses and bicycle helmets in ROTH exclusive design.”

Jean-Christophe Rattel, EKOI Founder: “I had the chance to attend this beautiful event twice, which gathers world triathlon elites, and all levels triathletes, men, women and children, in a very friendly and warm atmosphere. It is a real pride to be associated to this unique event in Europe, which once again proves our attachment to triathlon and its values!"

Ekoi is known for highly innovative premium products and is the outfitter of many World Tour cycling teams and triathlon professionals such as Anne Haug and Patrick Lange. The company was founded in 2001. It has quickly established itself as a leading company in France and a major player in the international cycling equipment market. Ekoi has pioneered direct online sales since 2008 and has chosen to cut out intermediaries and offer consumers premium products that combine design and technology to perfection. A particular advantage of Ekoi is that the glasses on offer can be personalized depending on the desired color of the frame or lens.

« Ultrasound device for Ukraine children's hospital New regulations on cancellation and entry fees for DATEV Challenge Roth powered by hep 2024 »